A CITMA careers webinar
to mark National Careers Week 2022
Friday 11 March 2022
12.30 – 1.30 pm
To mark National Careers Week, from 7 to 12 March 2022, the Chartered Institute of Trade Mark Attorneys (CITMA) organised a free webinar to introduce trade mark careers to would-be recruits. They invited supporters of our Careers in Ideas outreach campaign to share the event details with anyone they knew who might be interested in becoming a Chartered Trade Mark Attorney, in particular school and university students who hadn’t yet had much contact with the IP professions.
Brands and trade marks are key to every industry and business. Discover the wide range of career opportunities that this flourishing legal sector can offer you.
To learn more about the profession, this introductory session covered the basics of what a trade mark attorney does and how you can become one, offering a look at a fruitful and varied possible career. Speaker Mark Bearfoot explored different routes into the industry, inspired by his own unusual career path. He provided insight into the community of trade mark professionals that CITMA can offer, and the networking and career development opportunities that they provide.
- How to become a Chartered Trade Mark Attorney and the different routes into the profession.
- What a Chartered Trade Mark Attorney does and why it’s relevant to business and society.
- An understanding of what CITMA does and how it supports Chartered Trade Mark Attorneys.
Meet your speaker
Mark Bearfoot is Senior Legal Director at Tommy Hilfiger where he is responsible for leading their global IP and brand protection programme. He began his career working in IP law firms, including FieldFisher, Nucleus IP and Rouse, before making the move in-house to join The Coca-Cola Company in 2006 where he assisted in the management of their IP portfolio across Europe. He later moved to Harley-Davidson where he led their IP enforcement program for Europe, the Middle East and Africa.
This webinar was free of charge, including to non-members of CITMA.